<DOC>
	<DOCNO>NCT01387607</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tolerability pregabalin compare placebo management fibromyalgia adult .</brief_summary>
	<brief_title>A Study For Pregabalin In Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Male female patient , least 18 year age Meeting ACR ( America College Rheumatology ) criterion fibromyalgia ( ie , widespread pain present least 3 month , pain least 11 18 specific tender point site ) At screen ( V1 ) randomization ( V2 ) , patient must score less 40 mm Pain Visual Analog Scale ( VAS ) At randomization ( V2 ) , least 4 pain diary must complete satisfactorily within last 7 day average pain score must less 4 Patients less 30 % decrease Pain Visual Analog Scale ( VAS ) randomization ( V2 ) compare screening ( V1 ) Patients severe pain due condition ( eg , DPN PHN ) may confound assessment selfevaluation pain associate fibromyalgia Patients widespread inflammatory musculoskeletal disorder , widespread rheumatic disease fibromyalgia , active infection , untreated endocrine disorder CLcr le 60 mL/min ( estimate serum creatinine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pregabalin</keyword>
	<keyword>fibromyalgia</keyword>
</DOC>